Finance

Lists
ROSSARI:NSE
Rossari Biotech Ltd
₹411.15
-0.86%
(-3.55) 1D
Oct 26, 10:54:21 AM GMT+5:30  ·   INR
All symbols
SymbolPriceChange% Change
Generating top insights for ROSSARI...
Open
₹410.00
High
₹414.15
Low
₹401.00
Mkt. cap
22.84B
Avg. vol.
72.23K
Volume
34.23K
Dividend
0.12%
Quarterly dividend
₹0.13
Ex-dividend date
Jul 10, 2026
P/E ratio
14.92
52-wk high
₹663.00
52-wk low
₹375.00
EPS
₹27.56
No. of employees
585
Open
₹410.00
High
₹414.15
Low
₹401.00
Mkt. cap
22.84B
Avg. vol.
72.23K
Volume
34.23K
Dividend
0.12%
Quarterly dividend
₹0.13
Ex-dividend date
Jul 10, 2026
P/E ratio
14.92
52-wk high
₹663.00
52-wk low
₹375.00
EPS
₹27.56
No. of employees
585
News stories
From web sources and news partners
Profile
Rossari Biotech is an Indian chemical manufacturing company with a focus on specialty chemicals. It is also engaged in production of specialty enzymes and chemicals in India that is used in the pharmaceuticals, paper, construction, textiles, nutrition and animal health industries. The company was started in 2003 as a partnership firm titled Rossari Labtech and was incorporated into a company in 2009 and was renamed as Rossari Biotech. It has two R&D facilities, one at Silvassa manufacturing facility and the second in Dahej. Wikipedia
About Rossari Biotech Ltd
CEO-
Employees585
FoundedAug 10, 2009
Headquarters-
SectorSpeciality chemicals
Last report
Oct 19, 2026
Fiscal period
Q2 2027
₹7.02 / ₹5.90
+18.98%beat
Revenue / Est. (INR)
6.98B / 6.79B
+2.69%beat
Fiscal Q2 2027 earnings call
Waiting for the earnings call
At a glance
Insights from the latest news and reports
Previous reportsAll values in INR
Loading Previous Earnings...
Revenue
Net income
All values in INR
Dec 2025
Mar 2026
Jun 2026
Sep 2026
Revenue
5.82B
6.85B
6.97B
6.98B
Cost of goods sold
4.01B
5.04B
4.91B
4.77B
Cost of revenue
4.01B
5.04B
4.91B
4.77B
Research and development expenses
-
-
-
-
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
402.56M
463.26M
440.44M
436.16M
Operating expense
1.32B
1.44B
1.51B
1.63B
Total operating expenses
5.32B
6.48B
6.42B
6.41B
Operating income
492.59M
369.04M
550.05M
568.78M
Other non operating income
5.09M
-27.71M
31.87M
5.99M
EBT including unusual items
425.01M
642.43M
476.72M
492.69M
EBT excluding unusual items
425.01M
437.87M
476.72M
492.69M
Income tax expense
97.27M
182.76M
125.77M
103.62M
Effective tax rate
22.89%
28.45%
26.38%
21.03%
Other operating expenses
717.50M
736.59M
817.11M
896.62M
Net income
327.74M
459.67M
350.95M
389.07M
Net profit margin
5.63%
6.71%
5.03%
5.58%
Earnings per share
5.91
8.29
6.33
7.02
Interest and investment income
-
13.51M
-
-
Interest expense
-76.65M
-90.59M
-109.77M
-86.77M
Net interest expenses
-76.65M
-77.08M
-109.77M
-86.77M
Depreciation and amortization charges
196.14M
235.28M
256.15M
300.96M
EBITDA
645.98M
544.80M
725.80M
847.34M
Gain or loss from assets sale
-
-
-
-
Upcoming events
AI content may include mistakes. Learn more
Google apps